Cargando…
Treatment of overactive bladder in the aging population: focus on darifenacin
Anticholinergics are commonly used in primary and secondary care settings for the treatment of overactive bladder syndrome. The number of anticholinergic drugs available on the market is increasing and various studies, both observational and randomized controlled trials, have evaluated effectiveness...
Autores principales: | Jha, Swati, Parsons, Matthew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699645/ https://www.ncbi.nlm.nih.gov/pubmed/18046909 |
Ejemplares similares
-
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
por: Chughtai, Bilal, et al.
Publicado: (2008) -
A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder
por: Chancellor, M B, et al.
Publicado: (2008) -
Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin
por: Kay, G G, et al.
Publicado: (2008) -
Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy
por: Zinner, N, et al.
Publicado: (2008) -
Darifenacin hydrobromide
por: Selvanayagam, S., et al.
Publicado: (2009)